Clinical trials
Papillomavirus Infections trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
28 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2007 | 2 |
| 2008 | 2 |
| 2011 | 1 |
| 2012 | 3 |
| 2014 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 5 |
| 2021 | 2 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 19 |
| Recruiting | 4 |
| Unknown status | 3 |
| Active, not recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 3 |
| ANRS, Emerging Infectious Diseases | 2 |
| Assistance Publique - Hôpitaux de Paris | 2 |
| Centre Hospitalier Régional d'Orléans | 2 |
| Centre Hospitalier Universitaire de Besancon | 2 |
| Hospices Civils de Lyon | 2 |
| University Hospital, Bordeaux | 2 |
| University Hospital, Brest | 2 |
| Anaconda Pharma | 1 |
| Assistance Publique Hopitaux De Marseille | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Papillomavirus Infections | 28 |
| Uterine Cervical Neoplasms | 7 |
| Anus Neoplasms | 2 |
| Neoplasms | 2 |
| Vulvar Neoplasms | 2 |
| Abdominal Neoplasms | 1 |
| Acquired Immunodeficiency Syndrome | 1 |
| Basal Cell Carcinoma | 1 |
| Biliary Tract Neoplasms | 1 |
| Carcinoma | 1 |
Trials
Showing 51 to 28 of 28. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.